{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:57:10Z","timestamp":1794650230964,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001200"],"award-info":[{"award-number":["82001200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571226"],"award-info":[{"award-number":["81571226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ23H090002"],"award-info":[{"award-number":["LZ23H090002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Peripheral inflammation is an important feature of Parkinson\u2019s disease (PD). However, if and how CNS pathology is involved in the peripheral inflammation in PD remains to be fully investigated. Recently, the existence of meningeal lymphatics and its involvement in draining cerebral spinal fluid (CSF) to the cervical lymph node has been discovered. It is known that meningeal lymphatic dysfunction exists in idiopathic PD. The deep cervical lymph node (dCLN) substantially contributes to the drainage of the meningeal lymphatics. In addition, one of the lymphatics draining components, CSF, contains abundant \u03b1-synuclein (\u03b1-syn), a protein critically involved in PD pathogenesis and neuroinflammation. Thus, we began with exploring the possible structural and functional alterations of the dCLN in a PD mouse model (A53T mice) and investigated the role of pathological \u03b1-syn in peripheral inflammation and its potential underlying molecular mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, the transgenic mice (prnp-SNCA*A53T) which specifically overexpressed A53T mutant \u03b1-syn in CNS were employed as the PD animal model. Immunofluorescent and Hematoxylin and eosin staining were used to evaluate structure of dCLN. Inflammation in dCLNs as well as in bone-marrow-derived macrophages (BMDMs) was assessed quantitatively by measuring the mRNA and protein levels of typical inflammatory cytokines (including IL-1\u03b2, IL-6 and TNF-\u03b1). Intra-cisterna magna injection, flow cytometric sorting and electrochemiluminescence immunoassays were applied to investigate the lymphatic drainage of \u03b1-syn from the CNS. RNA-seq and Western blot were used to explore how pathological \u03b1-syn mediated the inflammation in PD mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results unequivocally revealed substantially enlarged dCLNs, along with slow lymphatic flow, and increased inflammation in the dCLNs of A53T mice. Oligomeric \u03b1-syn drained from CSF potently activated macrophages in the dCLN via endoplasmic reticulum (ER) stress. Notably, inhibition of ER stress effectively suppressed peripheral inflammation in PD mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings indicate that lymph node enlargement is closely related to macrophage activation, induced by meningeal lymphatics draining oligomeric \u03b1-syn, and contributes to the peripheral inflammation in PD. In addition, ER stress is a potential therapeutic target to ameliorate PD pathogenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-023-02770-5","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T14:03:05Z","timestamp":1681135385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The cervical lymph node contributes to peripheral inflammation related to Parkinson\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Zongran","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"2770_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng H, Wang P, Jankovic J. The genetics of Parkinson disease. Ageing Res Rev. 2018;42:72\u201385.","journal-title":"Ageing Res Rev"},{"key":"2770_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912.","journal-title":"Lancet"},{"key":"2770_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","volume":"44","author":"GE V\u00e1zquez-V\u00e9lez","year":"2021","unstructured":"V\u00e1zquez-V\u00e9lez GE, Zoghbi HY. Parkinson\u2019s disease genetics and pathophysiology. Annu Rev Neurosci. 2021;44:87\u2013108.","journal-title":"Annu Rev Neurosci"},{"key":"2770_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet. 2014;46:989\u201393.","journal-title":"Nat Genet"},{"key":"2770_CR5","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276:2045\u20137.","journal-title":"Science"},{"key":"2770_CR6","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. Parkinson disease. Nat Rev Dis Prim. 2017;3:17013.","journal-title":"Nat Rev Dis Prim"},{"key":"2770_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103:627-641.e627.","journal-title":"Neuron"},{"key":"2770_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D. \u03b1-Synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med. 2017;23:1\u201313.","journal-title":"Nat Med"},{"key":"2770_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/mds.26481","volume":"31","author":"AL Bergstr\u00f6m","year":"2016","unstructured":"Bergstr\u00f6m AL, Kallunki P, Fog K. Development of passive immunotherapies for synucleinopathies. Mov Disord. 2016;31:203\u201313.","journal-title":"Mov Disord"},{"key":"2770_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, Mollenhauer B, Blennow K, Calabresi P. CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol. 2019;18:573\u201386.","journal-title":"Lancet Neurol"},{"key":"2770_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM, Trojanowski JQ. Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci. 2013;14:626\u201336.","journal-title":"Nat Rev Neurosci"},{"key":"2770_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12035-012-8341-2","volume":"47","author":"M Xilouri","year":"2013","unstructured":"Xilouri M, Brekk OR, Stefanis L. \u03b1-Synuclein and protein degradation systems: a reciprocal relationship. Mol Neurobiol. 2013;47:537\u201351.","journal-title":"Mol Neurobiol"},{"key":"2770_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn2477","volume":"9","author":"P Brundin","year":"2008","unstructured":"Brundin P, Li JY, Holton JL, Lindvall O, Revesz T. Research in motion: the enigma of Parkinson\u2019s disease pathology spread. Nat Rev Neurosci. 2008;9:741\u20135.","journal-title":"Nat Rev Neurosci"},{"key":"2770_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, et al. Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol. 2014;128:639\u201350.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2770_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ana.26421","volume":"92","author":"Y Huang","year":"2022","unstructured":"Huang Y, Liu Z, Li N, Tian C, Yang H, Huo Y, Li Y, Zhang J, Yu Z. Parkinson\u2019s disease derived exosomes aggravate neuropathology in SNCA*A53T mice. Ann Neurol. 2022;92(2):230\u201345.","journal-title":"Ann Neurol"},{"key":"2770_CR16","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810248","volume":"11","author":"S Voet","year":"2019","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 2019;11: e10248.","journal-title":"EMBO Mol Med"},{"key":"2770_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.123","volume":"3","author":"C Barcia","year":"2012","unstructured":"Barcia C, Ros CM, Annese V, G\u00f3mez A, Ros-Bernal F, Aguado-Llera D, Mart\u00ednez-Pag\u00e1n ME, de Pablos V, Fernandez-Villalba E, Herrero MT. IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease. Cell Death Dis. 2012;3: e379.","journal-title":"Cell Death Dis"},{"key":"2770_CR18","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"2770_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"PL McGeer","year":"2003","unstructured":"McGeer PL, Schwab C, Parent A, Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol. 2003;54:599\u2013604.","journal-title":"Ann Neurol"},{"key":"2770_CR20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 2016;73:1316\u201324.","journal-title":"JAMA Neurol"},{"key":"2770_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","volume":"128","author":"V Grozdanov","year":"2014","unstructured":"Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A, Hengerer B, Kassubek J, et al. Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta Neuropathol. 2014;128:651\u201363.","journal-title":"Acta Neuropathol"},{"key":"2770_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ana.25557","volume":"86","author":"V Grozdanov","year":"2019","unstructured":"Grozdanov V, Bousset L, Hoffmeister M, Bliederhaeuser C, Meier C, Madiona K, Pieri L, Kiechle M, McLean PJ, Kassubek J, et al. Increased immune activation by pathologic alpha-synuclein in Parkinson\u2019s disease. Ann Neurol. 2019;86:593\u2013606.","journal-title":"Ann Neurol"},{"key":"2770_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12974-022-02413-1","volume":"19","author":"Z Liu","year":"2022","unstructured":"Liu Z, Chan RB, Cai Z, Liu X, Wu Y, Yu Z, Feng T, Yang Y, Zhang J. \u03b1-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson\u2019s disease. J Neuroinflamm. 2022;19:53.","journal-title":"J Neuroinflamm"},{"key":"2770_CR24","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep. 2016;13:3391\u20136.","journal-title":"Mol Med Rep"},{"key":"2770_CR25","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.3390\/ijms21228421","volume":"21","author":"C Marogianni","year":"2020","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G. Neurodegeneration and inflammation\u2014an interesting interplay in Parkinson\u2019s disease. Int J Mol Sci. 2020;21:8421.","journal-title":"Int J Mol Sci"},{"key":"2770_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/nan.12644","volume":"47","author":"P La Vitola","year":"2021","unstructured":"La Vitola P, Balducci C, Baroni M, Artioli L, Santamaria G, Castiglioni M, Cerovic M, Colombo L, Caldinelli L, Pollegioni L, Forloni G. Peripheral inflammation exacerbates \u03b1-synuclein toxicity and neuropathology in Parkinson\u2019s models. Neuropathol Appl Neurobiol. 2021;47:43\u201360.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2770_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2045-8118-11-17","volume":"11","author":"CA Bates","year":"2014","unstructured":"Bates CA, Zheng W. Brain disposition of \u03b1-synuclein: roles of brain barrier systems and implications for Parkinson\u2019s disease. Fluids Barriers CNS. 2014;11:17.","journal-title":"Fluids Barriers CNS"},{"key":"2770_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"YT Sui","year":"2014","unstructured":"Sui YT, Bullock KM, Erickson MA, Zhang J, Banks WA. Alpha synuclein is transported into and out of the brain by the blood\u2013brain barrier. Peptides. 2014;62:197\u2013202.","journal-title":"Peptides"},{"key":"2770_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12987-022-00334-y","volume":"19","author":"P Alam","year":"2022","unstructured":"Alam P, Holst MR, Lauritsen L, Nielsen J, Nielsen SSE, Jensen PH, Brewer JR, Otzen DE, Nielsen MS. Polarized \u03b1-synuclein trafficking and transcytosis across brain endothelial cells via Rab7-decorated carriers. Fluids Barriers CNS. 2022;19:37.","journal-title":"Fluids Barriers CNS"},{"key":"2770_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tins.2016.07.001","volume":"39","author":"D Raper","year":"2016","unstructured":"Raper D, Louveau A, Kipnis J. How do meningeal lymphatic vessels drain the CNS? Trends Neurosci. 2016;39:581\u20136.","journal-title":"Trends Neurosci"},{"key":"2770_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuron.2018.09.022","volume":"100","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Fu Z, Kipnis J. The meningeal lymphatic system: a new player in neurophysiology. Neuron. 2018;100:375\u201388.","journal-title":"Neuron"},{"key":"2770_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41586-019-1419-5","volume":"572","author":"JH Ahn","year":"2019","unstructured":"Ahn JH, Cho H, Kim J-H, Kim SH, Ham J-S, Park I, Suh SH, Hong SP, Song J-H, Hong Y-K, et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature. 2019;572:62\u20136.","journal-title":"Nature"},{"key":"2770_CR33","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","volume":"21","author":"A Louveau","year":"2018","unstructured":"Louveau A, Herz J, Alme MN, Salvador AF, Dong MQ, Viar KE, Herod SG, Knopp J, Setliff JC, Lupi AL, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380\u201391.","journal-title":"Nat Neurosci"},{"key":"2770_CR34","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, Wiig H, Alitalo K. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212:991\u20139.","journal-title":"J Exp Med"},{"key":"2770_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0312-x","volume":"14","author":"TK Patel","year":"2019","unstructured":"Patel TK, Habimana-Griffin L, Gao X, Xu B, Achilefu S, Alitalo K, McKee CA, Sheehan PW, Musiek ES, Xiong C, et al. Dural lymphatics regulate clearance of extracellular tau from the CNS. Mol Neurodegener. 2019;14:1\u20139.","journal-title":"Mol Neurodegener"},{"key":"2770_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Louveau A, Vaccari A, Smirnov I, Cornelison RC, Kingsmore KM, Contarino C, Onengut-Gumuscu S, Farber E, Raper D, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature. 2018;560:185\u201391.","journal-title":"Nature"},{"key":"2770_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-019-0147-y","volume":"8","author":"W Zou","year":"2019","unstructured":"Zou W, Pu T, Feng W, Lu M, Zheng Y, Du R, Xiao M, Hu G. Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated \u03b1-synuclein. Transl Neurodegener. 2019;8:1\u201317.","journal-title":"Transl Neurodegener"},{"key":"2770_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-fluid-122316-045259","volume":"50","author":"JE Moore","year":"2018","unstructured":"Moore JE, Bertram CD. Lymphatic system flows. Annu Rev Fluid Mech. 2018;50:459\u201382.","journal-title":"Annu Rev Fluid Mech"},{"key":"2770_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ar.21051","volume":"293","author":"G Sainte-Marie","year":"2010","unstructured":"Sainte-Marie G. The lymph node revisited: development, morphology, functioning, and role in triggering primary immune responses. Anat Rec (Hoboken). 2010;293:320\u201337.","journal-title":"Anat Rec (Hoboken)"},{"key":"2770_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nri3846","volume":"15","author":"AL Fletcher","year":"2015","unstructured":"Fletcher AL, Acton SE, Knoblich K. Lymph node fibroblastic reticular cells in health and disease. Nat Rev Immunol. 2015;15:350\u201361.","journal-title":"Nat Rev Immunol"},{"key":"2770_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron. 2002;34:521\u201333.","journal-title":"Neuron"},{"key":"2770_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","volume":"8","author":"C Tian","year":"2019","unstructured":"Tian C, Liu G, Gao L, Soltys D, Pan C, Stewart T, Shi M, Xie Z, Liu N, Feng T, Zhang J. Erythrocytic alpha-synuclein as a potential biomarker for Parkinson\u2019s disease. Transl Neurodegener. 2019;8:15.","journal-title":"Transl Neurodegener"},{"key":"2770_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","volume":"73","author":"K Matsuura","year":"1997","unstructured":"Matsuura K, Kabuto H, Makino H, Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods. 1997;73:45\u20138.","journal-title":"J Neurosci Methods"},{"key":"2770_CR44","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci. 2004;24:9434\u201340.","journal-title":"J Neurosci"},{"key":"2770_CR45","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J. 2005;19:533\u201342.","journal-title":"FASEB J"},{"key":"2770_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","volume":"13","author":"C Hetz","year":"2017","unstructured":"Hetz C, Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017;13:477\u201391.","journal-title":"Nat Rev Neurol"},{"key":"2770_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrc3800","volume":"14","author":"M Wang","year":"2014","unstructured":"Wang M, Kaufman RJ. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer. 2014;14:581\u201397.","journal-title":"Nat Rev Cancer"},{"key":"2770_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21:421\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2770_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.248","volume":"6","author":"C Lebeaupin","year":"2015","unstructured":"Lebeaupin C, Proics E, de Bieville CH, Rousseau D, Bonnafous S, Patouraux S, Adam G, Lavallard VJ, Rovere C, Le Thuc O, et al. ER stress induces NLRP3 inflammasome activation and hepatocyte death. Cell Death Dis. 2015;6: e1879.","journal-title":"Cell Death Dis"},{"key":"2770_CR50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/lrb.2015.0028","volume":"13","author":"M Jafarnejad","year":"2015","unstructured":"Jafarnejad M, Woodruff MC, Zawieja DC, Carroll MC, Moore JE Jr. Modeling lymph flow and fluid exchange with blood vessels in lymph nodes. Lymphat Res Biol. 2015;13:234\u201347.","journal-title":"Lymphat Res Biol"},{"key":"2770_CR51","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1016\/j.celrep.2019.10.103","volume":"29","author":"VG Martinez","year":"2019","unstructured":"Martinez VG, Pankova V, Krasny L, Singh T, Makris S, White IJ, Benjamin AC, Dertschnig S, Horsnell HL, Kriston-Vizi J, et al. Fibroblastic reticular cells control conduit matrix deposition during lymph node expansion. Cell Rep. 2019;29:2810-2822.e2815.","journal-title":"Cell Rep"},{"key":"2770_CR52","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.cell.2012.07.021","volume":"150","author":"W Kastenm\u00fcller","year":"2012","unstructured":"Kastenm\u00fcller W, Torabi-Parizi P, Subramanian N, L\u00e4mmermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell. 2012;150:1235\u201348.","journal-title":"Cell"},{"key":"2770_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28411","volume":"36","author":"EM Kline","year":"2021","unstructured":"Kline EM, Houser MC, Herrick MK, Seibler P, Klein C, West A, Tansey MG. Genetic and environmental factors in Parkinson\u2019s disease converge on immune function and inflammation. Mov Disord. 2021;36:25\u201336.","journal-title":"Mov Disord"},{"key":"2770_CR54","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik A, Stewart T, Zhang J. Alpha-synuclein as a biomarker for Parkinson\u2019s disease. Brain Pathol. 2016;26:410\u20138.","journal-title":"Brain Pathol"},{"key":"2770_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2019.01.005","volume":"175","author":"M Shi","year":"2019","unstructured":"Shi M, Sheng L, Stewart T, Zabetian CP, Zhang J. New windows into the brain: central nervous system-derived extracellular vesicles in blood. Prog Neurobiol. 2019;175:96\u2013106.","journal-title":"Prog Neurobiol"},{"key":"2770_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-immunol-032414-112116","volume":"33","author":"SE Bettigole","year":"2015","unstructured":"Bettigole SE, Glimcher LH. Endoplasmic reticulum stress in immunity. Annu Rev Immunol. 2015;33:107\u201338.","journal-title":"Annu Rev Immunol"},{"key":"2770_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ni.1857","volume":"11","author":"F Martinon","year":"2010","unstructured":"Martinon F, Chen X, Lee AH, Glimcher LH. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol. 2010;11:411\u20138.","journal-title":"Nat Immunol"},{"key":"2770_CR58","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri.2016.62","volume":"16","author":"J Grootjans","year":"2016","unstructured":"Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol. 2016;16:469\u201384.","journal-title":"Nat Rev Immunol"},{"key":"2770_CR59","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fnins.2019.00560","volume":"13","author":"E Colla","year":"2019","unstructured":"Colla E. Linking the endoplasmic reticulum to Parkinson\u2019s disease and alpha-synucleinopathy. Front Neurosci. 2019;13:560.","journal-title":"Front Neurosci"},{"key":"2770_CR60","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/cells8121471","volume":"8","author":"M Kusaczuk","year":"2019","unstructured":"Kusaczuk M. Tauroursodeoxycholate-bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives. Cells. 2019;8:1471.","journal-title":"Cells"},{"key":"2770_CR61","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature17631","volume":"532","author":"AM Keestra-Gounder","year":"2016","unstructured":"Keestra-Gounder AM, Byndloss MX, Seyffert N, Young BM, Ch\u00e1vez-Arroyo A, Tsai AY, Cevallos SA, Winter MG, Pham OH, Tiffany CR, et al. NOD1 and NOD2 signalling links ER stress with inflammation. Nature. 2016;532:394\u20137.","journal-title":"Nature"},{"key":"2770_CR62","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbi.2021.09.021","volume":"99","author":"F Huang","year":"2022","unstructured":"Huang F, Pariante CM, Borsini A. From dried bear bile to molecular investigation: a systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders. Brain Behav Immun. 2022;99:132\u201346.","journal-title":"Brain Behav Immun"},{"key":"2770_CR63","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657\u201373.","journal-title":"Nat Rev Immunol"},{"key":"2770_CR64","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics. Nat Rev Neurol. 2020;16:303\u201318.","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02770-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T15:04:20Z","timestamp":1681139060000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02770-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2770"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02770-5","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved in accordance with the Chinese Guidelines for the ethical review of laboratory animal welfare (LA2020056).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}